首页> 美国卫生研究院文献>Experimental Biology and Medicine >Glycogen synthase kinase 3β inhibition enhanced proliferation migration and functional re-endothelialization of endothelial progenitor cells in hypercholesterolemia microenvironment
【2h】

Glycogen synthase kinase 3β inhibition enhanced proliferation migration and functional re-endothelialization of endothelial progenitor cells in hypercholesterolemia microenvironment

机译:糖原合酶激酶3β抑制增强高胆固醇血症微环境中内皮祖细胞的增殖迁移和功能性重新内皮化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Hypercholesterolemia impairs the quantity and function of endothelial progenitor cell. We hypothesized that glycogen synthase kinase 3β activity is involved in regulating biological function of endothelial progenitor cells in hypercholesterolemia microenvironment. For study, endothelial progenitor cells derived from apolipoprotein E-deficient mice fed with high-fat diet were used. Glycogen synthase kinase 3β activity was interfered with glycogen synthase kinase 3β inhibitor lithium chloride or transduced with replication defective adenovirus vector expressing catalytically inactive glycogen synthase kinase 3β (GSK3β-KM). Functions of endothelial progenitor cells, proliferation, migration, secretion and network formation of endothelial progenitor cells were assessed in vitro. The expression of phospho-glycogen synthase kinase 3β, β-catenin and cyclinD1 in endothelial progenitor cells was detected by Western blot. The in vivo function re-endothelialization and vasodilation were also analyzed by artery injury model transplanted with glycogen synthase kinase 3β-inhibited endothelial progenitor cells. We demonstrated that while the proliferation, migration, network formation as well as VEGF and NO secretion were impaired in apolipoprotein E-deficient endothelial progenitor cells, glycogen synthase kinase 3β inhibition significantly improved all these functions. Apolipoprotein E-deficient endothelial progenitor cells showed decreased phospho-glycogen synthase kinase 3β, β-catenin and cyclinD1 expression, whereas these signals were enhanced by glycogen synthase kinase 3β inhibition and accompanied with β-catenin nuclear translocation. Our in vivo model showed that glycogen synthase kinase 3β inhibition remarkably increased re-endothelial and vasodilation. Taken together, our data suggest that inhibition of glycogen synthase kinase 3β is associated with endothelial progenitor cell biological functions both in vitro and in vivo. It might be an important interference target in hypercholesterolemia microenvironment.
机译:高胆固醇血症会损害内皮祖细胞的数量和功能。我们假设糖原合酶激酶3β活性参与高胆固醇血症微环境中调节内皮祖细胞的生物学功能。为了进行研究,使用了由高脂饮食喂养的载脂蛋白E缺陷型小鼠衍生的内皮祖细胞。糖原合酶激酶3β的活性受到糖原合酶激酶3β抑制剂氯化锂的干扰,或被表达有催化活性的糖原合酶激酶3β(GSK3β-KM)的复制缺陷型腺病毒载体转导。体外评估内皮祖细胞的功能,内皮祖细胞的增殖,迁移,分泌和网络形成。 Western blot法检测磷酸糖原合酶激酶3β,β-catenin和cyclinD1在内皮祖细胞中的表达。还通过移植了糖原合酶激酶3β抑制的内皮祖细胞的动脉损伤模型分析了体内功能的重新内皮化和血管舒张。我们证明,尽管载脂蛋白E缺陷型内皮祖细胞的增殖,迁移,网络形成以及VEGF和NO分泌受到损害,但糖原合酶激酶3β抑制作用却可以显着改善所有这些功能。缺乏载脂蛋白E的内皮祖细胞显示磷酸糖原合酶激酶3β,β-catenin和cyclinD1表达降低,而糖原合酶激酶3β抑制则增强了这些信号,并伴有β-catenin核易位。我们的体内模型显示糖原合酶激酶3β抑制显着增加了内皮重和血管舒张作用。两者合计,我们的数据表明,糖原合酶激酶3β的抑制与体外和体内内皮祖细胞的生物学功能有关。它可能是高胆固醇血症微环境中的重要干扰目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号